Sale!

Interferon – Beta IgG MAID Test Cost

Original price was: 4,030 د.إ.Current price is: 3,630 د.إ.

-10%

The Interferon-Beta (IFN-β) IgG MAID (Myxovirus Resistance Protein A Induction Deficiency) Test is a specialized diagnostic assay used to assess the presence and activity of neutralizing antibodies against interferon-beta in patients undergoing interferon-beta therapy. Interferon-beta is a common treatment for multiple sclerosis (MS) and certain other conditions, but over time, some patients may develop antibodies that neutralize the medication’s effects, leading to a decrease in treatment efficacy.

The test works by measuring the ability of the patient’s antibodies to interfere with the pathway interferon-beta uses to exert its effect, specifically looking at the induction of the Myxovirus Resistance Protein A (MxA) – a protein that is highly induced by interferon-beta and serves as a marker for its activity. By assessing the presence of these neutralizing antibodies, healthcare providers can make informed decisions about the continuation, modification, or cessation of interferon-beta therapy for their patients.

Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the Interferon-Beta IgG MAID Test offers a critical tool for personalized patient care. The test is priced at 3630 AED, reflecting the sophisticated nature of the assay and the specialized expertise required to interpret its results. Through this testing, DNA Labs UAE supports clinicians in optimizing treatment strategies for patients with conditions like multiple sclerosis, enhancing the potential for positive outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

INTERFERON – BETA IgG MAID Test

Cost: AED 3630.0

Symptoms and Diagnosis

The INTERFERON – BETA IgG MAID Test is a diagnostic tool used to detect antibodies against interferon-beta in the blood. Interferon-beta is a naturally occurring protein that helps regulate the immune system and has been used as a treatment for various autoimmune diseases, including multiple sclerosis.

The test involves exposing a patient’s blood sample to multiple forms of interferon-beta and using a technique called immunoblotting to detect any antibodies present in the blood that bind to the interferon-beta. This test can help determine if a patient has developed antibodies against interferon-beta, which can impact the effectiveness of treatment.

The presence of interferon-beta antibodies can lead to a reduction in the drug’s efficacy and potentially increase the risk of adverse reactions. Therefore, the INTERFERON – BETA IgG MAID test is often used in clinical practice to monitor patients receiving interferon-beta therapy and to guide treatment decisions.

Test Details

  • Test Name: INTERFERON – BETA IgG MAID Test
  • Components: Multiple Antigenic Immunoblot Assay
  • Price: AED 3630.0
  • Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Collect sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.
  • Report Delivery: Sample by 7th of the month; Report after 2-3 weeks
  • Method: Multianalyte Immunodetection (MAID)
  • Test Type: Multiple Sclerosis
  • Doctor: Neurologist
  • Test Department: OS
  • Pre Test Information: Submit sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Duly filled Test Send Out Consent Formis mandatory.

Importance of Test Results

The test results should be interpreted by a healthcare professional in conjunction with the patient’s clinical history and symptoms. The presence of interferon-beta antibodies can impact the effectiveness of treatment and potentially increase the risk of adverse reactions. Monitoring patients receiving interferon-beta therapy through the INTERFERON – BETA IgG MAID test can guide treatment decisions and ensure optimal patient care.

Test Name INTERFERON – BETA IgG MAID Test
Components
Price 3630.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Collect sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery Sample by 7th of the month; Report after 2??3 weeks
Method Multianalyte Immunodetection (MAID)
Test type Multiple Sclerosis
Doctor Neurologist
Test Department: OS
Pre Test Information Submit sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Duly filled Test Send Out Consent Formis mandatory.
Test Details

The INTERFERON-Beta IgG MAID (Multiple Antigenic Immunoblot Assay) test is a diagnostic tool used to detect antibodies against interferon-beta in the blood. Interferon-beta is a naturally occurring protein that helps regulate the immune system and has been used as a treatment for various autoimmune diseases, including multiple sclerosis.

The test involves exposing a patient’s blood sample to multiple forms of interferon-beta, and then using a technique called immunoblotting to detect any antibodies present in the blood that bind to the interferon-beta. This test can help determine if a patient has developed antibodies against interferon-beta, which can impact the effectiveness of treatment.

The presence of interferon-beta antibodies can lead to a reduction in the drug’s efficacy and potentially increase the risk of adverse reactions. Therefore, the INTERFERON-Beta IgG MAID test is often used in clinical practice to monitor patients receiving interferon-beta therapy and to guide treatment decisions.

It is important to note that the test results should be interpreted by a healthcare professional in conjunction with the patient’s clinical history and symptoms.